Drug intelligence / Profile preview

Ciklavit

Development stage
Unknown
Lead developer
Neimeth International Pharmaceuticals
Modality
Small Molecules
Administration
Oral
01

Overview

Ciklavit is an oral nutraceutical syrup developed by Neimeth International Pharmaceuticals for the management of sickle cell disease. It is formulated from an aqueous extract of *Cajanus cajan* (pigeon pea) seeds and is fortified with essential amino acids, vitamins (specifically Vitamin C/ascorbic acid), and minerals (specifically Zinc). The product functions as an anti-sickling agent, improving red blood cell deformability and reducing the frequency and severity of vaso-occlusive crises. Clinical evidence suggests it may also induce the production of fetal hemoglobin (HbF) and protect the liver from disease-related damage. It is marketed in Nigeria as the first indigenous nutritional supplement specifically for sickle cell anemia management.

Brand names
Ciklavit
Other names
Cajanus cajan extract
02

Targets

HbF (Fetal hemoglobin)

Beyond the preview

Go deeper on Ciklavit.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ciklavit.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call